BioSyent Pharma Inc. is focused on providing a distinguishable benefit to Canadian patients and their healthcare providers through innovation. With our deep expertise and experience in promoting women’s health, we strive to deliver products that are unique and provide meaningful therapeutic advantages over existing therapies. Our portfolio of healthcare products includes a patented oral hematinic (FeraMAX® Pd), a unique prescription hormone replacement therapy for menopause (Tibella®), an innovative suppository for vaginal dryness (RepaGyn®), and the first ever Acetaminophen + Ibuprofen combination available in Canada (Combogesic®).